A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

被引：0
|
作者：
Timothy J. Vreeland
Guy T. Clifton
Diane F. Hale
Robert C. Chick
Annelies T. Hickerson
Jessica L. Cindass
Alexandra M. Adams
Phillip M. Kemp Bohan
Robert H. I. Andtbacka
Adam C. Berger
James W. Jakub
Jeffrey J. Sussman
Alicia M. Terando
Thomas Wagner
George E. Peoples
Mark B. Faries
机构：
[1] Uniformed Services University of Health Sciences,Department of Surgery
[2] Brooke Army Medical Center,Department of Surgical Oncology
[3] University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[4] Brooke Army Medical Center,Department of Surgery
[5] Huntsman Cancer Institute,undefined
[6] Rutgers Cancer Institute of New Jersey,undefined
[7] Mayo Clinic,undefined
[8] University of Cincinnati Cancer Institute,undefined
[9] USC Norris Comprehensive Cancer Center,undefined
[10] Orbis Health Solutions,undefined
[11] Cancer Vaccine Development Program,undefined
[12] The Angeles Clinic,undefined
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6126 / 6137
页数：11
相关论文
共 50 条
  • [31] A Phase II/III Randomized Controlled Trial of Adjuvant Radiotherapy, Concurrent Chemoradiotherapy after Surgery Versus Surgery Alone in Patients with Stage IIB-III Esophageal Squamous Cell Carcinoma
    Ni, W.
    Xiao, Z.
    Zhou, Z.
    Wang, X.
    Chen, D.
    Qinfu, F.
    Liang, J.
    Lv, J.
    Bi, N.
    Deng, L.
    Zhang, T.
    Wang, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E193 - E193
  • [32] Phase III randomized controlled trial of adjuvant chemoimmunotherapy in patients with resected primary lung cancer
    Kimura, H.
    Matsui, Y.
    Nakajima, T.
    Iizasa, T.
    Ishikawa, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
    John M. Kirkwood
    Michele Del Vecchio
    Jeffrey Weber
    Christoph Hoeller
    Jean-Jacques Grob
    Peter Mohr
    Carmen Loquai
    Caroline Dutriaux
    Vanna Chiarion-Sileni
    Jacek Mackiewicz
    Piotr Rutkowski
    Petr Arenberger
    Gaelle Quereux
    Tarek M. Meniawy
    Paolo A. Ascierto
    Alexander M. Menzies
    Piyush Durani
    Maurice Lobo
    Federico Campigotto
    Brian Gastman
    Georgina V. Long
    Nature Medicine, 2024, 30 : 607 - 607
  • [34] A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
    Ni, Wenjie
    Yu, Shufei
    Zhang, Wencheng
    Xiao, Zefen
    Zhou, Zongmei
    Chen, Dongfu
    Feng, Qinfu
    Liang, Jun
    Lv, Jima
    Gao, Shugeng
    Mao, Yousheng
    Xue, Qi
    Sun, Kelin
    Liu, Xiangyang
    Fang, Dekang
    Li, Jian
    Wang, Dali
    BMC CANCER, 2020, 20 (01)
  • [35] Radiotherapy Plus Chemotherapy With or Without Surgical Resection for Stage III Non-Small-Cell Lung Cancer: a Phase III Randomized Controlled Trial
    Papachristofilou, Alexandros
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 405 - 407
  • [36] A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
    Wenjie Ni
    Shufei Yu
    Wencheng Zhang
    Zefen Xiao
    Zongmei Zhou
    Dongfu Chen
    Qinfu Feng
    Jun Liang
    Jima Lv
    Shugeng Gao
    Yousheng Mao
    Qi Xue
    Kelin Sun
    Xiangyang Liu
    Dekang Fang
    Jian Li
    Dali Wang
    BMC Cancer, 20
  • [37] Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial - Invited commentary
    Wanebo, HJ
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (01) : 77 - 79
  • [38] Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results
    Oh, J.
    Barve, M.
    Bedell, C.
    Kuhn, J.
    Fine, B.
    Heffernan, T. P.
    Matthews, C. M.
    Stringer, C. A.
    Koon, E. C.
    Goodman, H.
    Fleming, E. L.
    DeMars, L. R.
    Bergman, M. K.
    Pappen, B. O.
    Kumar, P.
    Maples, P. B.
    Senzer, N.
    Nemunaitis, J.
    MOLECULAR THERAPY, 2014, 22 : S241 - S242
  • [39] Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results
    Senzer, Neil
    Barve, Minal
    Bedell, Cynthia
    Oh, Jonathan
    Kuhn, Joseph
    Fine, Bruce
    Heffernan, Thomas P.
    Matthews, Carolyn M.
    Stringer, C. Allen
    Koon, E. Colin
    Lifshitz, Samuel
    Pappen, Beena O.
    Kumar, Padmasini
    Maples, Phillip B.
    Nemunaitis, John
    MOLECULAR THERAPY, 2013, 21 : S194 - S195
  • [40] Adjuvant Therapy With Capecitabine Postpones Recurrence of Hepatocellular Carcinoma After Curative Resection: A Randomized Controlled Trial
    Yong Xia
    Yinghe Qiu
    Jun Li
    Lehua Shi
    Kui Wang
    Tao Xi
    Feng Shen
    Zhenlin Yan
    Mengchao Wu
    Annals of Surgical Oncology, 2010, 17 : 3137 - 3144
12345